Search

Yong Zhou

Examiner (ID: 10884)

Most Active Art Unit
2477
Art Unit(s)
2619, 2419, 2477
Total Applications
358
Issued Applications
281
Pending Applications
1
Abandoned Applications
79

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18939873 [patent_doc_number] => 20240035012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => ENGINEERED ACE2 OLIGOMERS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/022467 [patent_app_country] => US [patent_app_date] => 2021-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12923 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022467 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022467
ENGINEERED ACE2 OLIGOMERS AND USES THEREOF Aug 22, 2021 Pending
Array ( [id] => 18955178 [patent_doc_number] => 20240043505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => CORONAVIRUS NANOBODIES AND METHODS FOR THEIR USE AND IDENTIFICATION [patent_app_type] => utility [patent_app_number] => 18/022033 [patent_app_country] => US [patent_app_date] => 2021-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022033 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022033
CORONAVIRUS NANOBODIES AND METHODS FOR THEIR USE AND IDENTIFICATION Aug 18, 2021 Pending
Array ( [id] => 19142463 [patent_doc_number] => 20240141302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => NOVEL BACTERIOPHAGE HAVING ENTEROTOXIGENIC ESCHERICHIA COLI-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 18/278567 [patent_app_country] => US [patent_app_date] => 2021-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5669 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278567 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/278567
NOVEL BACTERIOPHAGE HAVING ENTEROTOXIGENIC ESCHERICHIA COLI-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME Jun 14, 2021 Pending
Array ( [id] => 18485200 [patent_doc_number] => 20230212528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => MATERIALS AND METHODS FOR VIRAL PURIFICATION [patent_app_type] => utility [patent_app_number] => 18/000525 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28511 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000525 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000525
MATERIALS AND METHODS FOR VIRAL PURIFICATION May 31, 2021 Pending
Array ( [id] => 18647854 [patent_doc_number] => 20230293630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => Coronavirus T Cell Epitopes and Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/760402 [patent_app_country] => US [patent_app_date] => 2021-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47402 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760402 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/760402
Coronavirus T Cell Epitopes and Uses Thereof Feb 10, 2021 Pending
Array ( [id] => 18523011 [patent_doc_number] => 20230233665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => ANTI- SARS-COV-2-INFECTION PROTEIN AND VACCINE [patent_app_type] => utility [patent_app_number] => 17/923303 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7157 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923303 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923303
ANTI- SARS-COV-2-INFECTION PROTEIN AND VACCINE Sep 17, 2020 Pending
Array ( [id] => 17982577 [patent_doc_number] => 20220348613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => ADENO-ASSOCIATED VIRUSES AND METHODS AND MATERIALS FOR MAKING AND USING ADENO-ASSOCIATED VIRUSES [patent_app_type] => utility [patent_app_number] => 17/638451 [patent_app_country] => US [patent_app_date] => 2020-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43785 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638451 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/638451
ADENO-ASSOCIATED VIRUSES AND METHODS AND MATERIALS FOR MAKING AND USING ADENO-ASSOCIATED VIRUSES Aug 27, 2020 Pending
Array ( [id] => 17895298 [patent_doc_number] => 20220304960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING VACCINIA VIRUS AND HYDROXYUREA AS ACTIVE INGREDIENT FOR TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/638143 [patent_app_country] => US [patent_app_date] => 2019-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11450 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638143 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/638143
PHARMACEUTICAL COMPOSITION COMPRISING VACCINIA VIRUS AND HYDROXYUREA AS ACTIVE INGREDIENT FOR TREATMENT OF CANCER Aug 25, 2019 Pending
Menu